Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Payables (2016 - 2025)

Orthopediatrics has reported Payables over the past 10 years, most recently at $21.3 million for Q4 2025.

  • Quarterly results put Payables at $21.3 million for Q4 2025, up 105.66% from a year ago — trailing twelve months through Dec 2025 was $21.3 million (up 105.66% YoY), and the annual figure for FY2025 was $21.3 million, up 105.66%.
  • Payables for Q4 2025 was $21.3 million at Orthopediatrics, up from $8.5 million in the prior quarter.
  • Over the last five years, Payables for KIDS hit a ceiling of $22.6 million in Q3 2023 and a floor of $8.5 million in Q3 2025.
  • Median Payables over the past 5 years was $12.7 million (2023), compared with a mean of $14.0 million.
  • Biggest five-year swings in Payables: skyrocketed 107.58% in 2023 and later tumbled 48.43% in 2024.
  • Orthopediatrics' Payables stood at $9.3 million in 2021, then increased by 19.57% to $11.2 million in 2022, then grew by 13.44% to $12.6 million in 2023, then decreased by 18.27% to $10.3 million in 2024, then surged by 105.66% to $21.3 million in 2025.
  • The last three reported values for Payables were $21.3 million (Q4 2025), $8.5 million (Q3 2025), and $12.7 million (Q2 2025) per Business Quant data.